TCA
LLY icon

Trifecta Capital Advisors’s Eli Lilly LLY Stock Holding History

Trifecta Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8M Buy
25,670
+39
+0.2% +$39.8K 3.97% 5
2026
Q1 		$23.6M Sell
25,631
-93
-0.4% -$94.3K 3.65% 7
2025
Q4 		$27.6M Buy
25,724
+260
+1% +$249K 4.09% 6
2025
Q3 		$19.4M Buy
25,464
+683
+3% +$508K 2.95% 8
2025
Q2 		$19.3M Buy
24,781
+2,712
+12% +$2.11M 3.22% 7
2025
Q1 		$18.2M Sell
22,069
-74
-0.3% -$61.6K 3.82% 7
2024
Q4 		$17.1M Buy
22,143
+196
+0.9% +$162K 3.38% 9
2024
Q3 		$19.4M Buy
21,947
+131
+0.6% +$118K 4.07% 8
2024
Q2 		$19.8M Buy
21,816
+298
+1% +$238K 4.37% 7
2024
Q1 		$16.7M Sell
21,518
-1,804
-8% -$1.28M 4.07% 8
2023
Q4 		$13.6M Sell
23,322
-2,463
-10% -$1.44M 3.76% 8
2023
Q3 		$13.8M Buy
25,785
+720
+3% +$371K 4.45% 5
2023
Q2 		$11.8M Sell
25,065
-1,873
-7% -$785K 3.78% 7
2023
Q1 		$9.25M Buy
26,938
+275
+1% +$92.7K 3.26% 8
2022
Q4 		$9.75M Buy
+26,663
New +$9.45M 3.89% 7

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trifecta Capital Advisors's LLY Position: Q2 2026 in Review

Trifecta Capital Advisors increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $39.8K and bringing the position to 25,670 shares worth $30.8M. The position accounts for 3.97% of the portfolio, ranked #5.

Trifecta Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trifecta Capital Advisors held 25,670 shares of Eli Lilly worth $30.8M as of Q2 2026.
  • Trifecta Capital Advisors bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 3.97% of Trifecta Capital Advisors's portfolio in Q2 2026, its #5 holding.
  • Trifecta Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.